Sharescart Research Club logo
Products
Research
Tools
About
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel
Apollo Green₹ 72 (28.6%)ASK Investment₹ 895 (-3.2%)AVPL ₹ 49 (0%)Bootes Impex₹ 775 (-8.8%)CIAL ₹ 442 (-0.5%)CSK ₹ 254 (-3.1%)ESDS Software₹ 478 (2.8%)Garuda Aerospace₹ 468 (-2.1%)Goodluck Defence₹ 385 (16%)Hero Motors₹ 325 (0%)Hinduja Leyland₹ 248 (0%)ICL Fincorp₹ 25 (0%)Incred Holdings₹ 154 (2.7%)Kineco Limited₹ 3285 (0%)Lava ₹ 60 (15.4%)Market Simplified₹ 26 (-7.1%)Matrix Gas₹ 12 (-20%)Motilal Oswal₹ 12.25 (-2%)MSEI ₹ 6.35 (-2.3%)NCDEX ₹ 368 (-1.6%)NSE ₹ 1985 (-2%)Onix Renewable₹ 68 (21.4%)OYO ₹ 23 (-4.2%)OYO Assets₹ 9.25 (-7%)Philips India₹ 1250 (0%)Polymatech Electronics₹ 56 (-3.4%)SBI Mutual₹ 768 (-0.9%)Taparia Tools₹ 6050 (0%)VCI Chemical₹ 64 (0%)Zepto ₹ 40 (-4.8%)

15 Days Price Change

Hemant Surgical Inds IPO

Closing In

  • days
  • Hours
  • Minutes
  • Seconds
Profile
Issue Size --
Profile
Price Range 85  to  90 per share
Profile
Min Investment ₹90
Profile
Lot Size 1
Profile
Face Value ₹10
Profile
Draft Prospectus
Invest Before the IPO Goes Live

Buy unlisted shares early and participate in the growth before public listing.

Profile
  • Basic Info
  • IPO Tentative Timetable
  • IPO Lot Size
  • Subscription Status
  • Financials
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Ratios
  • Growth Rates
  • Other info

Overview

Hemant Surgical Industries Ltd is a renowned company that specializes in the manufacturing and distribution of medical and surgical equipment. With a strong presence in the healthcare industry, the company has established itself as a trusted provider of high-quality products. Hemant Surgical Industries Ltd offers a wide range of medical instruments, including surgical instruments, hospital furniture, medical disposables, orthopedic implants, and diagnostic equipment. With a commitment to innovation and quality, Hemant Surgical Industries Ltd consistently strives to meet the evolving needs of the medical community. The company employs skilled professionals and utilizes advanced technologies to ensure precision and reliability in its products. Through stringent quality control measures, Hemant Surgical Industries Ltd maintains exceptional standards, complying with industry regulations and international norms. As a customer-centric organization, Hemant Surgical Industries Ltd focuses on delivering excellent service and maintaining long-term relationships with clients. With its dedication to healthcare excellence, the company has earned a strong reputation and continues to contribute significantly to the medical field. Read More

Basic Info

Face Value 10 per share

Price 85  to  90 per share

P/E (x) 11.7

Sales( Cr.) 107

PAT( Cr.) 8

EPS 7.7

Draft Prospectus

Exchange BSE-SME

Promoter

Company Promoters

Hanskumar Shamji Shah Kaushik Hanskumar Shah Hemant Praful Shah

Pre Issue Share Holding 100%

Post Issue Share Holding 68.08%

Listing Details:

Listing Price: 171

Listing Gain: 47.37%

Current Price: 408

Gain On Issue: 408 | 0%

GMP: --

GMP %: -- %

IPO Tentative Timetable

Opening Date May 24, 2023
Closing Date May 26, 2023
Allotment May 29, 2023
Refund May 30, 2023
Delivery of Shares May 30, 2023
Listing Date May 31, 2023

IPO Lot Size

Application Lots Shares Amount
Retail (Min) 1 1600 144,000
Retail (Max) 1 1600 144,000
S-HNI (Min) 2 3200 288,000
S-HNI (Max) 6 9600 864,000
B-HNI (Min) 7 11200 1,008,000

Objective of the Issue

1. Funding Capital Expenditure towards the installation of additional plant and machinery 2. Funding to meet working capital requirements 3. General Corporate Purpose 4. Issue expenses

Issue

Category Nos Bid Bid (x)
QIB 1380000 56649000 41.1x
NII 414000 84149640 203.3x
Retail 966000 153333180 158.7x
EMP 0 0 0x
Total 2760000 385572000 139.7x

Net Sales (in cr.)

Total Income (in cr.)

Operating Profit (in cr.)

Net Profit (in cr.)

Shareholder Funds (in cr.)

Total Assets (in cr.)

Hemant Surgical Inds Profit & Loss

#(Fig in Cr.) Mar 2025 TTM
Net Sales 107
Other Income 5
Total Income 112
Total Expenditure 98
Operating Profit 14
Interest 2
Depreciation 1
Exceptional Income / Expenses 0
Profit Before Tax 10
Provision for Tax 2
Profit After Tax 8
Adjustments 0
Profit After Adjustments 8
Adjusted Earnings Per Share 7.7

Hemant Surgical Inds Balance Sheet

#(Fig in Cr.) Mar 2025
Shareholder's Funds 63
Minority's Interest 0
Borrowings 23
Other Non-Current Liabilities 0
Total Current Liabilities 61
Total Liabilities 148
Fixed Assets 40
Other Non-Current Assets 19
Total Current Assets 89
Total Assets 148

Hemant Surgical Inds Cash Flow

#(Fig in Cr.) Mar 2025
Opening Cash & Cash Equivalents 13
Cash Flow from Operating Activities 9
Cash Flow from Investing Activities -30
Cash Flow from Financing Activities 18
Net Cash Inflow / Outflow -4
Closing Cash & Cash Equivalent 10

Hemant Surgical Inds Ratios

# Mar 2025
Earnings Per Share (Rs) 7.7
CEPS(Rs) 9.07
DPS(Rs) 0
Book NAV/Share(Rs) 60.51
Core EBITDA Margin(%) 8.53
EBIT Margin(%) 12
Pre Tax Margin(%) 9.81
PAT Margin (%) 7.54
Cash Profit Margin (%) 8.88
ROA(%) 5.43
ROE(%) 12.73
ROCE(%) 13.58
Receivable days 69.76
Inventory Days 147.65
Payable days 187.95
PER(x) 12.94
Price/Book(x) 1.65
Dividend Yield(%) 0
EV/Net Sales(x) 1.18
EV/Core EBITDA(x) 8.83
Net Sales Growth(%) 0
EBIT Growth(%) 0
PAT Growth(%) 0
EPS Growth(%) 0
Debt/Equity(x) 0.49
Current Ratio(x) 1.45
Quick Ratio(x) 0.75
Interest Cover(x) 5.5
Total Debt/Mcap(x) 0.3

Sihora Industries Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 0% 0% 0% 0%
Operating Profit CAGR 0% 0% 0% 0%
PAT CAGR 0% 0% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 325% NA% NA% NA%
ROE Average 13% 13% 13% 13%
ROCE Average 14% 14% 14% 14%

Company Contact Information

Hemant Surgical Industries Ltd.

502,5th Floor, Ecstasy Business Park Co-op Socteiy Limited, J. S. D. Road Mulund (West)

IPO Lead Manager(s)

Hemant Surgical Industries Ltd.

Hem Securities Ltd.

Registrar Info

Hemant Surgical Industries Ltd.

Frequently Asked Questions

All You Need To Know About IPO

When you leave without vesting, generally unvested ESOPs are cancelled. Vested ESOPs usually can be exercised after you depart, often within 3 to 6 months, depending on the company's ESOP plan.

For companies listed on a stock exchange, you can sell the shares any time after you exercise the ESOP option and the shares are in your demat account. If the company is unlisted or otherwise a startup, you can only sell the shares if and when the company announces a buyback or has a process for secondary sales.

Whenever you exercised your options to hold shares, you entered into a market risk situation, and if the valuation of the company drops, so do the shares.

Yes. ESOPs are valuable to the employer in that the employer is able to retain the best talent, align employee interests with company goals, and preserve cash while rewarding performance.

Wealth Icon
Don’t Miss Out on Unlisted Shares

Open your account today and gain instant access to top unlisted shares and pre-IPO opportunities.

whatsapp

Error!